BioSupply Trends Quarterly logo
Close this search box.

First Cancer Patients Receive mRNA Therapy in Clinical Trial

image of mRNA therapy

Imperial College Healthcare NHS Trust has enrolled the first United Kingdom (UK) patients who have received an experimental messenger RNA (mRNA) therapy — a type of immunotherapy treatment called mRNA-4359 — in its Phase I/II clinical trial.